ORCID as entered in ROS

Select Publications
2009, 'Chemotherapy for ovarian cancer in the older adult', Current Treatment Options in Oncology, 10, pp. 159 - 170, http://dx.doi.org/10.1007/s11864-009-0093-5
,2009, 'Radiopathological review of small bowel carcinoid tumours', Journal of Medical Imaging and Radiation Oncology, 53, pp. 1 - 12, http://dx.doi.org/10.1111/j.1754-9485.2009.02031.x
,2009, 'WITHDRAWN: Chemotherapy and radiotherapy for inoperable advanced pancreatic cancer.', Cochrane Database of Systematic Reviews Online, pp. CD002093
,2009, 'Cancer in the older adult: a tale of two disciplines', Journal of Internal Medicine, 39, pp. 771 - 775
,2008, 'Attitudes of advanced Australian medical oncology trainees to rural practice', Asia Pacific Journal of Clinical Oncology, 4, pp. 34 - 41, http://dx.doi.org/10.1111/j.1743-7563.2008.00146.x
,2007, 'Late recurrence of osteosarcoma [1]', Internal Medicine Journal, 37, pp. 420 - 422, http://dx.doi.org/10.1111/j.1445-5994.2007.01346.x
,2007, 'International society of geriatric oncology chemotherapy taskforce: Evaluation of chemotherapy in older patients - An analysis of the medical literature', Journal of Clinical Oncology, 25, pp. 1832 - 1843, http://dx.doi.org/10.1200/JCO.2007.10.6583
,2007, 'International Society of Geriatric Oncology (SIOG) recommendations for the adjustment of dosing in elderly cancer patients with renal insufficiency', European Journal of Cancer, 43, pp. 14 - 34, http://dx.doi.org/10.1016/j.ejca.2006.11.004
,2007, 'Renal insufficiency in elderly cancer patients: International Society of Geriatric Oncology clinical practice recommendations', Annals of Oncology, 18, pp. 1314 - 1321, http://dx.doi.org/10.1093/annonc/mdm011
,2006, 'Gemcitabine and oxaliplatin followed by paclitaxel and carboplatin as first line therapy for patients with suboptimally debulked, advanced epithelial ovarian cancer. A phase II trial of sequential doublets. The GO-First Study', Gynecologic Oncology, 103, pp. 439 - 445, http://dx.doi.org/10.1016/j.ygyno.2006.03.017
,2006, 'Chemotherapy and radiotherapy for inoperable advanced pancreatic cancer.', Cochrane Database of Systematic Reviews Online, 3, pp. CD002093
,2006, 'Chemotherapy and radiotherapy for pancreatic cancer', Cochrane Database of Systematic Reviews, 4
,2005, 'Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer', Women S Oncology Review, 5, pp. 109 - 111, http://dx.doi.org/10.1080/14733400500178618
,2005, 'Reply to the letter "Limitations of bedside estimates of renal function", by M. J. Dooley and S. G. Poole', ANNALS OF ONCOLOGY, 16, pp. 990 - 990, http://dx.doi.org/10.1093/annonc/mdi174
,2005, 'Limitations of Wright formula estimates of renal function (multiple letters) [3]', Annals of Oncology, 16, pp. 989 - 990, http://dx.doi.org/10.1093/annonc/mdi173
,2005, 'Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer', The Women's Oncology Review, 5, pp. 109 - 111, http://dx.doi.org/10.3109/14733400500178618
,2004, 'Gemcitabine and oxaliplatin followed by paclitaxel and carboplatin as first line therapy for patients with advanced epithelial ovarian cancer. A phase II trial of sequential doublets. (GO-FIRST)', Journal of Clinical Oncology, 22, pp. 5034 - 5034, http://dx.doi.org/10.1200/jco.2004.22.90140.5034
,2004, 'Gemcitabine and oxaliplatin followed by paclitaxel and carboplatin as first line therapy for patients with advanced epithelial ovarian cancer. A phase II trial of sequential doublets. (GO-FIRST)', Journal of Clinical Oncology, 22, pp. 5034 - 5034, http://dx.doi.org/10.1200/jco.2004.22.14_suppl.5034
,2004, 'A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer', Women S Oncology Review, 4, pp. 135 - 136, http://dx.doi.org/10.1080/14733400410001728483
,2004, 'Evaluation of the Cockroft-Gault, Jelliffe and Wright formulae in estimating renal function in elderly cancer patients', Annals of Oncology, 15, pp. 291 - 295, http://dx.doi.org/10.1093/annonc/mdh079
,2004, 'Recent advances in management of small-cell lung cancer', Cancer Treatment Reviews, 30, pp. 521 - 543
,2003, 'Use of fluorodeoxyglucose positron emission tomography scans in patients with advanced germ cell tumour following chemotherapy: Single-centre experience with long-term follow up', Internal Medicine Journal, 33, pp. 427 - 435, http://dx.doi.org/10.1046/j.1445-5994.2003.00456.x
,2003, 'A dose-escalating study of oral eniluracil/5-fluorouracil plus oxaliplatin in patients with advanced gastrointestinal malignancies', Annals of Oncology, 14, pp. 864 - 866, http://dx.doi.org/10.1093/annonc/mdg254
,2003, 'Poor uptake of influenza vaccinations in patients receiving cytotoxic chemotherapy', International Journal of Clinical Practice, 57, pp. 542 - 543, http://dx.doi.org/10.1111/j.1742-1241.2003.tb10547.x
,2003, 'Pseudomyxoma peritonei: The 'controversial' disease', International Journal of Gynecological Cancer, 13, pp. 413 - 418, http://dx.doi.org/10.1136/ijgc-00009577-200307000-00003
,2003, 'Pseudomyxoma peritonei: the 'controversial' disease', International Journal of Gynecological Cancer, 13, pp. 413 - 418, http://dx.doi.org/10.1136/ijgc-00009577-200307000-00003
,2002, 'Influenza vaccination and chemotherapy: A shot in the dark?', Supportive Care in Cancer, 10, pp. 462 - 465, http://dx.doi.org/10.1007/s00520-001-0337-9
,2002, 'Sentinel node biopsy: An in depth appraisal', Critical Reviews in Oncology Hematology, 44, pp. 45 - 70, http://dx.doi.org/10.1016/S1040-8428(02)00018-5
,2002, 'Quality of life: It's never too late', Journal of Clinical Oncology, 20, pp. 2915 - 2917, http://dx.doi.org/10.1200/JCO.2002.20.13.2915
,2002, 'Unexpected serious toxicity with chemotherapy and antiangiogenic combinations: Time to take stock!', Journal of Clinical Oncology, 20, pp. 1446 - 1448, http://dx.doi.org/10.1200/JCO.2002.20.6.1446
,2002, 'Symptom palliation in advanced oesophageal cancer', Current Therapeutics, 43, pp. 33 - 35
,2002, 'P10. Effect of GFR methodology on carboplatin dosing', Nuclear Medicine Communications, 23, pp. 408 - 408, http://dx.doi.org/10.1097/00006231-200204000-00090
,2001, 'Collecting duct carcinoma of the kidney associated with the sickle cell trait', International Journal of Clinical Practice, 55, pp. 415 - 417
,2001, 'Is there any place for cytotoxic chemotherapy in endometrial cancer?', Best Practice and Research Clinical Obstetrics and Gynaecology, 15, pp. 447 - 467, http://dx.doi.org/10.1053/beog.2001.0188
,2001, 'Is there quality in clinical benefit?', Annals of Oncology, 12, pp. 1191 - 1193, http://dx.doi.org/10.1023/A:1012474308888
,2001, 'Management of small cell lung cancer', Expert Review of Anticancer Therapy, 1, pp. 197 - 210, http://dx.doi.org/10.1586/14737140.1.2.197
,2000, 'Varicella-zoster infection after allogeneic bone marrow transplantation: Incidence, risk factors and prevention with low-dose aciclovir and ganciclovir', Bone Marrow Transplantation, 25, pp. 657 - 664, http://dx.doi.org/10.1038/sj.bmt.1702190
,1999, 'An unusual alkaline phosphatase isoenzyme associated with gastric carcinoma', ANNALS OF CLINICAL BIOCHEMISTRY, 36, pp. 743 - 748, http://dx.doi.org/10.1177/000456329903600607
,2025, 'AGITG MONARCC: A Randomized Phase 2 Study of Panitumumab Monotherapy and Panitumumab Plus 5-Fluorouracil as First-Line Therapy for Older Patients With RAS and BRAF Wild Type Metastatic Colorectal Cancer. A Study by the Australasian Gastro-Intestinal Trials Group (AGITG)', in Clinical Colorectal Cancer, pp. 120 - 128, http://dx.doi.org/10.1016/j.clcc.2024.11.003
,2023, 'ASCEND: A randomised, double-blinded, phase II study of gemcitabine and nab-paclitaxel with CEND-1/LSTA1 or placebo in patients with untreated metastatic pancreatic ductal adenocarcinoma.', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, IL, Chicago, presented at Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), IL, Chicago, 02 June 2023 - 06 June 2023
,2023, 'Circulating tumor DNA (ctDNA) as a marker of residual disease and recurrence in resected stage I-IV epithelial ovarian cancer (EOC)', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, IL, Chicago, presented at Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), IL, Chicago, 02 June 2023 - 06 June 2023
,2023, 'Olaparib in HR-deficient (HRD), metastatic triple-negative breast cancer (TNBC) and relapsed ovarian cancer (ROC) without germline mutations in BRCA1 or BRCA2: Phase 2 EMBRACE trial.', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, IL, Chicago, presented at Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), IL, Chicago, 02 June 2023 - 06 June 2023
,2021, 'Modelling the societal outcomes of immunotherapy in cancer care in Australia', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 66 - 66, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000717281500034&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2021, 'GERIATRIC ONCOLOGY IN THE INSTAGRAM ERA: PHOTOVOICE TO ENABLE PATIENT-CENTERED CARE AND SHARED DECISION MAKING', in INNOVATION IN AGING, OXFORD UNIV PRESS, pp. 26 - 26, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000842009900094&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2020, 'ELderly Functional Index (ELFI): Validation of a self-reported measure of functional status in cancer patients.', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, ELECTR NETWORK, presented at Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), ELECTR NETWORK, 29 May 2020 - 31 May 2020
,2020, 'Identifying biomarkers to guide immunotherapy treatment of cancer of unknown primary.', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, ELECTR NETWORK, presented at Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), ELECTR NETWORK, 29 May 2020 - 31 May 2020
,2019, 'Avelumab treatment of metastatic merkel cell carcinoma (mMCC): Updated findings from Australian patients enrolled in an expanded access program(EAP)', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 184 - 184, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000493438400298&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2019, 'Exercise and androgen deprivation therapy: Current practice and future direction at a regional cancer centre', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 198 - 198, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000493438400328&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2019, 'Feasibility of the electronic rapid fitness assessment (eRFA) in an Australian regional cancer centre', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 194 - 194, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000493438400320&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2019, 'Modelling the health outcomes of immuno-oncology therapies in cancer care in Australia', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 151 - 152, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000493438400230&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,